Overall, the key components of JSP for the treatment of DKD were Quercetin, Kaempferol, Stigmasterol, Wogonin, Beta-sitosterol, Baicalein, and Dehydroeburicoic acid, whereas the key pathways involved were the AGE/RAGE signaling pathway, PI3K/AKT signaling pathway, MAPK signaling pathway, etc. Here, AKT1 is linked to diabetic kidney disease.